PRIMARY IMMUNODEFICIENCIES TESTING REQUISITION

Size: px
Start display at page:

Download "PRIMARY IMMUNODEFICIENCIES TESTING REQUISITION"

Transcription

1 MOLECULAR GENETICS LABORATORY For courier service and/or inquiries, please contact Fax: Shipping Address: 3333 Burnet Avenue, Room R1042 Cincinnati, OH PRIMARY IMMUNODEFICIENCIES TESTING REQUISITION All Information Must Be Completed Before Sample Can Be Processed PATIENT INFORMATION Patient Name:,, Last First MI Home Phone: MR# Date of Birth / / Gender: Male Female ETHNIC/RACIAL BACKGROUND (Choose All) European American (White) Native American or Alaskan Pacific Islander African-American (Black) Asian-American Ashkenazi Jewish ancestry Latino-Hispanic (specify country/region of origin) Other (specify country/region of origin) BILLING INFORMATION (Choose ONE method of payment) o REFERRING INSTITUTION Institution: City/State/Zip: Accounts Payable Contact Name: Phone: Fax: o COMMERCIAL INSURANCE* Insurance can only be billed if requested at the time of service. Policy Holder Name: Gender: Date of Birth / / Authorization Number: Insurance ID Number: Insurance Name: Insurance Address: City/State/Zip: Insurance Phone Number: * PLEASE NOTE: We will not bill Medicaid, Medicaid HMO, or Medicare except for the following: CCHMC Patients, CCHMC Providers, or Designated Regional Counties. If you have questions, please call for complete details. SAMPLE/SPECIMEN INFORMATION Has patient received a bone marrow transplant? Yes No Note: For post-transplant patients, we accept pre-transplant samples or posttransplant skin fibroblasts ONLY (blood, saliva, and cytobrushes are not accepted). Culturing of skin fibroblasts is done at an additional charge. SPECIMEN TYPE: Amniotic fluid Blood Cytobrushes Cord blood CVS Bone marrow Saliva Tissue (specify): Specimen Date: / / Time: Specimen Amount: Each test requires 3 ml of whole blood in EDTA tube. Please call before sending alternate tissue samples, and for free cytobrush or saliva collection kits. DRAWN BY: *Phlebotomist must initial tube of specimen to confirm sample identity REFERRING PHYSICIAN Physician Name (print): Phone: ( ) Fax: ( ) Genetic Counselor/Lab Contact Name: Phone: ( ) Fax: ( ) Date: / / Referring Physician Signature (REQUIRED) Patient signed completed ABN Medical Necessity Regulations: At the government s request, the Molecular Genetics Laboratories would like to remind all physicians that when ordering tests that will be paid under federal health care programs, including Medicare and Medicaid programs, that these programs will pay only for those tests the relevant program deems to be (1) included as covered services, (2) reasonable, (3) medically necessary for the treatment and diagnosis of the patient, and (4) not for screening purposes.

2 Patient Name: Date of Birth: INDICATIONS/DIAGNOSIS/ICD-9 CODE Reason for Testing: o Mutation detection in suspected affected patient o Carrier testing o Prenatal diagnosis (by previous arrangement only) TEST(S) REQUESTED Primary Immunodeficiency (Comprehensive testing) Immunology Exome 351 gene panel utilizing Whole Exome Sequencing (WES) technology* Reflex to deletion/duplication of single gene(s) (specify): *See page 5 for comprehensive gene list Autoimmune lymphoproliferative syndrome Autoimmune Lymphoproliferative Syndrome (ALPS) Panel by next generation sequencing (NGS) (CASP8, CASP10, FADD, FAS, FASLG, ITK, KRAS, MAGT1, NRAS) Reflex to deletion/duplication of single gene(s) (specify): o FAS (TNFRSF6) Reflex to deletion/duplication of FAS (TNFRSF6) o FASLG (TNFSF6) Reflex to deletion/duplication of FASLG (TNFSF6) o CASP10 Reflex to deletion/duplication of CASP10 o Somatic FAS sequence analysis of sorted double-negative T cell (DNTC) (You MUST call in advance for specimen requirements and to schedule this test) Bone marrow failure syndromes o Bone Marrow Failure Syndromes Panel by next-generation sequencing (NGS) (AP3B1, BRCA2 (FANCD1), BRIP1 (FANCJ), CSF3R, CXCR4, DKC1, ELANE, ERCC4 (FANCQ), FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, G6PC3, GATA1, GATA2, GFI1, HAX1, LAMTOR2 (ROBLD3), LYST, MPL, NHP2 (NOLA2), NOP10 (NOLA3), PALB2 (FANCN), RAB27A, RAC2, RAD51C (FANCO), RBM8A, RMRP, RPL5, RPL11, RPL15, RPL26, RPL35A, RPS7, RPS10, RPS17, RPS19, RPS24, RPS26, RTEL1, SBDS, SLC37A4, SLX4 (FANCP), SRP72, TAZ, TERC (htr), TERT, TINF2, USB1, VPS13B, VPS45, WAS, WIPF1, WRAP53 (TCAB1, WDR79)) o Shwachman Diamond syndrome (SBDS) Chromosome breakage syndrome panel (ATM, BLM, LIG4, NBN, NHEJ1) Reflex to deletion/duplication of single gene(s) (specify): Diamond-Blackfan anemia panel (GATA1, RPL5, RPL11, RPL15, RPL26, RPL35A, RPS7, RPS10, RPS17, RPS19, RPS24, RPS26) See page 5 for additional deletion/duplication information Dyskeratosis congenita Panel (DKC1, NHP2 (NOLA2), NOP10 (NOLA3), RTEL1, TERC (htr), TERT, TINF2, WRAP53 (WDR79, TCAB1)) Reflex to deletion/duplication of single gene(s) (specify): Familial hemophagocytic lymphohistiocytosis Hemophagocytic Lymphohistiocytosis (HLH) Panel (AP3B1, BLOC1S6, CD27, GATA2, ITK, LYST, MAGT1, PRF1, RAB27A, SH2D1A, SLC7A7, STX11, STXBP2, UNC13D (MUNC13-4), XIAP (BIRC4)) Reflex to deletion/duplication of single gene(s) (specify): If inadequate DNA is present, we will prioritize testing according to our FHL testing algorithm, unless you indicate a different order of prioritization below. UNC13D (MUNC13-4) Reflex to deletion/duplication of UNC13D (MUNC13-4) PRF1 Reflex to deletion/duplication of PRF1 RAB27A (Griscelli syndrome) Reflex to deletion/duplication of RAB27A STXBP2 Reflex to deletion/duplication of STXBP2 STX11 Reflex to deletion/duplication of STX11 Fanconi anemia Fanconi Anemia Panel by next-generation sequencing (NGS) (BRCA2 (FANCD1), BRIP1 (FANCJ), ERCC4 (FANCQ), FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, PALB2 (FANCN), RAD51C (FANCO), SLX4 (FANCP)) Reflex to deletion/duplication of single gene(s) (specify): o FANCA Reflex to deletion/duplication of FANCA o FANCC Reflex to deletion/duplication of FANCC o FANCC c.456+4a>t (IVS4+4 A>T) [common Ashkenazi mutation] only o FANCG Reflex to deletion/duplication of FANCG Lymphoproliferative disorders (Including EBV-Related) o SH2D1A Reflex to deletion/duplication of SH2D1A o XIAP (BIRC4) Reflex to deletion/duplication of XIAP (BIRC4) o ITK Reflex to deletion/duplication of ITK o MAGT1 Reflex to deletion/duplication of MAGT1

3 Patient Name: Date of Birth: TEST(S) REQUESTED, CONTINUED Severe Combined Immunodeficiencies Severe combined immunodeficiency panel by next-generation sequencing (NGS) (ADA, CD3D, CD3E, DCLRE1C, FOXN1 (WHN), IL2RG, IL7R, JAK3, LIG4, NHEJ1, ORAI1, PNP, PTPRC, RAG1, RAG2, RMRP, STAT5B, STIM1, TBX1, ZAP70) o X-linked severe combined immunodeficiency (IL2RG) Reflex to deletion/duplication of IL2RG Severe congenital neutropenia Inherited neutropenia panel by next-generation sequencing (NGS) (AP3B1, CSF3R, CXCR4, ELANE (ELA2), G6PC3, GATA1, GATA2, GFI1, HAX1, LAMTOR2 (ROBLD3), LYST, RAB27A, RAC2, SBDS, SLC37A4, TAZ, USB1, VPS13B, VPS45, WAS, WIPF1) o ELANE (ELA2) Reflex to deletion/duplication of ELANE (ELA2) o HAX1 Reflex to deletion/duplication of HAX1 o WAS (males only) Reflex to deletion/duplication of WAS See page 5 for additional deletion/duplication information Note: Single gene sequencing is available for all genes listed in the next-generation panels. Other Primary Immunodeficiencies o IPEX syndrome (FOXP3) Reflex to deletion/duplication of FOXP3 o Wiskott-Aldrich syndrome (WAS) Reflex to deletion/duplication of WAS o X-linked hyper IgM immunodeficiency (CD40LG) Reflex to deletion/duplication of CD40LG Rare Immunodeficiencies o CTLA4 Reflex to deletion/duplication of CTLA4 o GATA2 Reflex to deletion/duplication of GATA2 o LRBA Reflex to deletion/duplication of LRBA o PIK3CD Reflex to deletion/duplication of PIK3CD o STAT3 Reflex to deletion/duplication of STAT3 Targeted (family specific) mutation analysis for gene Proband s name Proband s DOB Proband s mutation Please call to discuss any family-specific mutation analysis with genetic counselor prior to shipment. CUSTOM GENE SEQUENCING Gene(s) to be sequenced (specify): Only genes with clear published functional relationship to rare diseases are accepted. Suspected syndrome/ condition: Please choose one of the following: o Full gene(s) sequencing o Full gene(s) sequencing with reflex to deletion and duplication analysis, if indicated (please see list of genes available for del/dup at Familial mutation analysis Proband s name: Proband s DOB: Proband s mutation: Patient s relation to proband: DELETION AND DUPLICATION ASSAY Gene(s) to be analyzed (specify): Please see list of available genes at: Suspected syndrome/ condition: Please choose one of the following: o Deletion and duplication analysis of gene(s) specified above o Deletion and duplication analysis of gene(s) specified above with reflex to sequencing, if indicated Analysis of gene(s) specified above from previously analyzed deletion and duplication Familial deletion analysis Proband s name: Proband s DOB: Proband s mutation: Patient s relation to proband:

4 Patient Name: Date of Birth: IMMUNE DEFICIENCIES, AUTOIMMUNE DISORDERS AND BONE MARROW FAILURE SYNDROMES Clinical History is Required for all NGS Panels CLINICAL HISTORY Has patient received a bone marrow transplant? Yes No If yes, date of bone marrow transplant Percent engraftment General Acute liver failure Fever(s) Failure to thrive (Hepato)splenomegaly Lethargy Respiratory insufficiency/failure Sudden unexplained coma/death Age at diagnosis Head and Neck Abnormal CT/MRI of brain; specify Dysmorphic facies Enlarged lymph nodes Microcephaly Oral leukoplakia Small lymph nodes and/or tonsils Thymic hypoplasia Skin Alopecia Eczema Hypopigmentation/ hyperpigmentation Rash/dermatitis Telangiectasia of eyes or skin Dysplastic nails Other skin lesions; specify Hematologic History Bone marrow failure Cytopenias (2 of 3 cell lineages) Leukopenia/neutropenia Red cell anemia Thrombocytopenia/small platelets Oncologic History Lymphoma; specify type Myelodysplasia/AML Other leukemia; specify type Recurrent primary tumors; specify types Solid tumor; specify type Other; specify Infectious Disease History Recurrent, unusual or difficult to treat infections viral bacterial fungal Recurrent pneumonia, ear infections or sinusitis Recurrent deep abscesses of the organs or skin Multiple courses of antibiotics or IV antibiotics necessary to clear infections Other; specify Laboratory findings Anemia Decreased telomere length Neutropenia/leukopenia Thrombocytopenia Abnormal ALPS panel Abnormal mitogen stimulation Abnormal lymphocyte subsets Abnormal TREC assay Abnormal B cell function; specify Abnormal T cell function; specify Low or absent NK function Complementation group correction (specify) Increased chromosome breakage ferritin soluble IL2Rα triglycerides and/or fibrinogens Abnormal protein assay by flow cytometry; specify Other; specify Congenital abnormalities/malformations/dysmorphic features (Please specify) Other Symptoms (Please specify) Related disease history of other family members (Please specify)

5 ADDITIONAL INFORMATION IMMUNOLOGY EXOME PANEL GENES TESTED ACP5 ACTB ADA ADA2 ADAMTS13 ADAR AICDA AIRE AK2 AP3B1 APOL1 ATM BLM BLNK BLOC1S3 BLOC1S6 BRCA2 BRIP1 BTK C1QA C1QB C1QC C1S C2 C3 C4BPA C5 C6 C7 C8A C8B C8G C9 CARD11 CARD14 CARD9 CARMIL2 CASP10 CASP8 CAVIN1 CD19 CD247 CD27 CD3D CD3E CD3G CD40 CD40LG CD46 CD59 CD70 CD79A CD79B CD81 CD8A CDCA7 CEBPE CFB CFD CFH CFHR1 CFHR3 CFHR5 CFI CFP CHD7 CIITA CLEC7A CLPB COG6 COLEC11 CORO1A CR2 CREBBP CSF3R CTC1 CTLA4 CTPS1 CTSC CXCR4 CYBA CYBB DCLRE1C DGKE DHFR DKC1 DNAJC21 DNMT3B DOCK8 DTNBP1 ELANE EPG5 ERCC2 ERCC3 ERCC4 ERCC6L2 ETV6 F11 F13A1 F13B F5 F7 F8 F9 FADD FANCA FANCB FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM FAS FASLG FCN3 FERMT3 FGA FGB FOXN1 FOXP3 FPR1 G6PC G6PC3 G6PD GATA1 GATA2 GFI1 GP1BA GP1BB GP9 GTF2H5 HAX1 HELLS HPS1 HPS3 HPS4 HPS5 HPS6 ICOS IFIH1 IFNGR1 IFNGR2 IGLL1 IKBKB IKZF1 IL10 IL10RA IL10RB IL12B IL12RB1 IL17F IL17RA IL1RN IL2 IL21R IL2RA IL2RG IL36RN IL7R INSR IRAK4 IRF8 ISG15 ITCH ITGAM ITGB2 ITK JAGN1 JAK2 JAK3 KMT2D KRAS LAMTOR2 LCK LIG1 LIG4 LPIN2 LRBA LRRC8A LYST MAGT1 MALT1 MAN2B1 MANBA MASP1 MASP2 MBL2 MC2R MCM4 MEFV MLPH MPL MPO MRE11 MS4A1 MTHFD1 MVK MYD88 MYH9 MYO5A MYSM1 NBN NCF2 NCF4 NCSTN NFKB1 NFKB2 NFKBIA NHEJ1 NHP2 NKX2-5 NLRC4 NLRP12 NLRP3 NOD2 NOP10 NRAS ORAI1 PALB2 PARN PCCA PCCB PEPD PGM3 PI4KA PIGA PIK3CD PIK3R1 PLCG2 PLG PMM2 PNP POLE PRF1 PRKCD PRKDC PROC PROS1 PSENEN PSMB8 PSTPIP1 PTPRC RAB27A RAC2 RAD50 RAD51C RAG1 RAG2 RBCK1 RBM8A RFX5 RFXANK RFXAP RHOH RNASEH2A RNASEH2B RNASEH2C RNF168 RPL11 RPL15 RPL26 RPL35A RPL36 RPL5 RPS10 RPS15 RPS15A RPS17 RPS19 RPS24 RPS26 RPS27A RPS28 RPS29 RPS7 RPSA RTEL1 RUNX1 SAMHD1 SBDS SEMA3E SH2D1A SH3BP2 SKIV2L SLC29A3 SLC35A1 SLC35C1 SLC37A4 SLC39A4 SLC46A1 SLC7A7 SLX4 SMARCAL1 SP110 SPINK5 SRP72 STAT1 STAT2 STAT3 STAT5B STIM1 STK4 STX11 STXBP2 TAP1 TAP2 TAPBP TAZ TBK1 TBX1 TCIRG1 TCN2 TERC TERT THBD TICAM1 TINF2 TLR3 TMC6 TMC8 TNFAIP3 TNFRSF13B TNFRSF13C TNFRSF1A TNFRSF4 TNFSF12 TRADD TRAF3 TRAF3IP2 TREX1 TRNT1 TTC37 TTC7A TYK2 UNC119 UNC13D UNG USB1 VPS13B VPS45 WAS WDR1 WIPF1 WRAP53 XIAP XK ZAP70 ZBTB24 Deletion/Duplication analysis is currently unavailable for the following genes: ACP5, ACTB, ADA, ADAR, APOL1, C8G, CARMIL2, CAVIN1, CD46, CD70, CFH, CFHR1, CFHR3, CFHR5, CLPB, CORO1A, CTC1, CTPS1, DCLRE1C, DHFR, DNAJC21, EPG5, ERCC6L2, ETV6, FANCD2, FERMT3, GTF2H5, HELLS, IFIH1, IGLL1, IKBKB, IL2, ITGAM, JAGN1, KMT2D, MC2R, MRE11, MYSM1, NCSTN, NFKB1, NFKB2, NLRC4, PARN, PEPD, PGM3, PI4KA, PIGA, POLE, PRKCD, PROS1, PSENEN, RPL15, RPL36, RPS15, RPS15A, RPS17, RPS28, RPS29, RPSA, RUNX1, SBDS, SEMA3E, SKIV2L, SLC29A3, SLC39A4, STAT2, STAT5B, TNFRSF4, TNFSF12, TRADD, TRAF3IP2, TRNT1, WDR

The circulating T helper subsets and regulatory T cells in patients with common variable immunodeficiency with no monogenic disease

The circulating T helper subsets and regulatory T cells in patients with common variable immunodeficiency with no monogenic disease 1 Supplementary data The circulating T helper subsets and regulatory T cells in patients with common variable immunodeficiency with no monogenic disease Azizi et al. 2 Table S1. Excluded 373 genes variants

More information

PRIMARY IMMUNODEFICIENCIES GENE PANEL

PRIMARY IMMUNODEFICIENCIES GENE PANEL PRIMARY IMMUNODEFICIENCIES GENE PANEL Gene symbol Depth Coverage OMIM (reads) (avg %) disease Description ACP5 96 95 200 Spondyloenchondrodysplasia with immune dysregulation ACTB 101 17 243310 Baraitser-Winter

More information

The Changing Diagnostic Landscape of Primary Immune Deficiency

The Changing Diagnostic Landscape of Primary Immune Deficiency The Changing Diagnostic Landscape of Primary Immune Deficiency Dr. Sabeena Selvarajah Paediatric Immunology Fellow, Princess Margaret Hospital for Children, Term infant girl of non-consanguineous parents

More information

ESID Online Registry: Diseases and Genes

ESID Online Registry: Diseases and Genes ESID Online Registry: Diseases and Genes as of 17.07.2017 - Please send ideas and questions to esid-registry@uniklinik-freiburg.de Main category Sub category PID Diagnosis Gene Autoinflammatory disorders

More information

150 International Union of Immunological Societies Primary Immunodeficiency Disease Classification. IgG. loss of function

150 International Union of Immunological Societies Primary Immunodeficiency Disease Classification. IgG. loss of function 2008 Vol. 20No. 2175 IgG 46 T T T loss of function 150 International Union of Immunological Societies Primary Immunodeficiency Disease Classification Committee 8 1 1 T B 2 3 4 5 6 7 8 120 1 B 2 Infectious

More information

Defects of Innate Immunity

Defects of Innate Immunity Defects of Innate Immunity TLR signalling IRAK4 and MyD88 AR Same clinical phenotype for both genes (Recurrent) invasive bacterial infections: Meningitis and septicemia >> skin Pneumococcus >> Staph aureus

More information

The University of Chicago Genetic Services Laboratories

The University of Chicago Genetic Services Laboratories The University of Chicago tic Services Laboratories 5841 S. Maryland Ave., Rm. G701, MC 0077, Chicago, Illinois 60637 ucgslabs@genetics.uchicago.edu dnatesting.uchicago.edu CLIA #: 14D0917593 CAP #: 18827-49

More information

UKGTN Testing Criteria

UKGTN Testing Criteria UKGTN Testing Criteria Test name: Inherited Bone Marrow Failure Syndromes 44 Gene Panel Approved name disorder/(s): See Appendix 1 Approved name (s): See Appendix 1 (s): (s): Patient name: Patient postcode:

More information

HTG EdgeSeq Immuno-Oncology Assay Gene List

HTG EdgeSeq Immuno-Oncology Assay Gene List A2M ABCB1 ABCB11 ABCC2 ABCG2 ABL1 ABL2 ACTB ADA ADAM17 ADGRE5 ADORA2A AICDA AKT3 ALCAM ALO5 ANA1 APAF1 APP ATF1 ATF2 ATG12 ATG16L1 ATG5 ATG7 ATM ATP5F1 AL BATF BA BCL10 BCL2 BCL2L1 BCL6 BID BIRC5 BLNK

More information

Whole exome sequencing Gene package Primary Immunodeficiency Disorders version 2,

Whole exome sequencing Gene package Primary Immunodeficiency Disorders version 2, Whole Exome Sequencing Gene package Primary Immunodeficiency Disorders, version 2, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture,

More information

Whole exome sequencing Gene package Primary Immunodeficiency Disorders version 2.1,

Whole exome sequencing Gene package Primary Immunodeficiency Disorders version 2.1, Whole Exome Sequencing Gene package Primary Immunodeficiency Disorders, version 2.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired

More information

Next Generation Sequencing Panel for Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure

Next Generation Sequencing Panel for Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Next Generation Sequencing Panel for Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Clinical Features and Molecular Genetics: Hereditary myeloid malignancies were considered rare, but

More information

Next Generation Sequencing Panel for Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure

Next Generation Sequencing Panel for Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Next Generation Sequencing Panel for Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Clinical Features and Molecular Genetics: Hereditary myeloid malignancies were considered rare, but

More information

New Directions in Aplastic Anemia

New Directions in Aplastic Anemia 11//15 New Directions in Aplastic Anemia ANDREW C. DI ETZ, MD, MSCR PEDIATRIC BLOOD AND MARROW TRANSPLANTATION CHILDREN S HOSPITAL LOS ANGELES, UNIVERSITY OF SOUTHERN CALIFORNIA Outline Ø Changes in Immunosuppressive

More information

GENETIC TESTING FOR FANCONI ANEMIA

GENETIC TESTING FOR FANCONI ANEMIA GENETIC TESTING FOR FANCONI ANEMIA Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices

More information

Advances in genetic studies of inherited bone marrow failure syndromes and their associated malignancies

Advances in genetic studies of inherited bone marrow failure syndromes and their associated malignancies Review Article Advances in genetic studies of inherited bone marrow failure syndromes and their associated malignancies Qi-Hong Yu 1, Shu-Ye Wang 2, Zhanhe Wu 3 1 Department of Gastroenterology, Chang

More information

A CANCER GENETICIST S (2 ND ) BEST FRIEND IS THEIR PATHOLOGIST. Dr Alan Donaldson Consultant in Clinical Genetics St Michaels Hospital Bristol

A CANCER GENETICIST S (2 ND ) BEST FRIEND IS THEIR PATHOLOGIST. Dr Alan Donaldson Consultant in Clinical Genetics St Michaels Hospital Bristol A CANCER GENETICIST S (2 ND ) BEST FRIEND IS THEIR PATHOLOGIST Dr Alan Donaldson Consultant in Clinical Genetics St Michaels Hospital Bristol Topics to be covered How pathology contributes to genetic diagnosis

More information

Susceptibilité génétique aux infections

Susceptibilité génétique aux infections Susceptibilité génétique aux infections capucine.picard@inserm.fr Centre d étude des déficits immunitaires, hôpital Necker-Enfants Malades et Laboratoire de Génétique Humaine des Maladies Infectieuses

More information

Cancer Risks Associated With Inherited Mutations in Ovarian Cancer Susceptibility Genes Beyond BRCA1 and BRCA2

Cancer Risks Associated With Inherited Mutations in Ovarian Cancer Susceptibility Genes Beyond BRCA1 and BRCA2 AWARD NUMBER: W81XWH-15-1-0084 TITLE: Cancer Risks Associated With Inherited Mutations in Ovarian Cancer Susceptibility Genes Beyond BRCA1 and BRCA2 PRINCIPAL INVESTIGATOR: Elizabeth Swisher CONTRACTING

More information

Genetic Predisposition Syndromes in Myeloid Malignancies

Genetic Predisposition Syndromes in Myeloid Malignancies Genetic Predisposition Syndromes in Myeloid Malignancies Lucy A. Godley, M.D., Ph.D. Section of Hematology/Oncology Departments of Medicine and Human Genetics The University of Chicago My patients and

More information

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH ADULTS & Young People

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH ADULTS & Young People HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH ADULTS & Young People Histiocytosis UK Introduction Despite the misery it causes, Histiocytosis is too rare a disease to have generated substantial research in medical

More information

7/13/2017. PreventionGenetics. How are genes associated with bone marrow failure?

7/13/2017. PreventionGenetics. How are genes associated with bone marrow failure? Personalized Medicine: tic Testing and the Implications for Future Therapies Preventiontics Michael Chicka, PhD, Molecular ticist, Preventiontics Founded in 2004 in Marshfield Wisconsin by Dr. Jim Weber

More information

Division of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition.

Division of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition. Page 1 of 10 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostics Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 Patient

More information

Selective IgA deficiency Common variable immunodeficiency (CVID) Specific antibody deficiency Antibody deficiencies Antibody deficiencies

Selective IgA deficiency Common variable immunodeficiency (CVID) Specific antibody deficiency Antibody deficiencies Antibody deficiencies Warning signs of Primary Immunodeficiency for specialty care physicians The clinical presentation of PID can be diverse. However, there are clinical findings at the level of different organs and systems

More information

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH CHILDREN

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH CHILDREN HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH CHILDREN Histiocytosis UK Introduction Despite the misery it causes, Histiocytosis is too rare a disease to have generated substantial research in medical circles.

More information

Division of Genomic Diagnostics CANCER GENOMIC TEST REQUISITION Page 1 of 6

Division of Genomic Diagnostics CANCER GENOMIC TEST REQUISITION Page 1 of 6 Page 1 of 6 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostic Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 Patient

More information

CD Marker Antibodies. atlasantibodies.com

CD Marker Antibodies. atlasantibodies.com CD Marker Antibodies atlasantibodies.com CD Marker Antibodies Product Name Product Number Validated Applications Anti-ACE HPA029298 IHC,WB Anti-ACKR1 HPA016421 IHC Anti-ACKR1 HPA017672 IHC Anti-ADAM17

More information

Eosinophils! 40! 30! 20! 10! 0! NS!

Eosinophils! 40! 30! 20! 10! 0! NS! A Macrophages Lymphocytes Eosinophils Neutrophils Percentage (%) 1 ** 4 * 1 1 MMA SA B C Baseline FEV1, % predicted 15 p = 1.11 X 10-9 5 CD4:CD8 ratio 1 Supplemental Figure 1. Cellular infiltrate in the

More information

EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR)

EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR) THE UNIVERSITY OF TEXAS *Required Fields PHYSICIAN! FACILITY/ CLIENT INFORMATION MDAndersonefief &ter MaltgararEettcy 'REQUESTING PHYSICIAN Division of Pathology! Laboratory Medicine Services Test Requisition

More information

Next Generation Sequencing Panel for Hereditary Lymphoma

Next Generation Sequencing Panel for Hereditary Lymphoma Next ration Sequencing Panel for Hereditary Lymphoma : Lymphomas are cancers originating from the lymphoid tissues, and can be divided into two broad categories, Hodgkin lymphoma and non-hodgkin lymphoma,

More information

The inherited bone marrow failure syndromes are a

The inherited bone marrow failure syndromes are a NADP(H) quinone (oxido) reductase1. J Biol Chem. 2007;282(47): 34365-71. 14. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP)

More information

Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer

Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer www.impactjournals.com/oncotarget/ Oncotarget, Supplementary Materials 2016 Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer Supplementary Materials Supplementary

More information

International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity

International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity J Clin Immunol (2018) 38:96 128 https://doi.org/10.1007/s10875-017-0464-9 ORIGINAL ARTICLE International Union of Immunological Societies: 2017 Primary Immuno Diseases Committee Report on Inborn Errors

More information

The Genome Scan in IBD

The Genome Scan in IBD SESSION III WORKSHOPS HOT TOPICS FROM BED TO BENCH TO POLICY The Genome Scan in IBD Charlie Lees, PhD FRCP(Ed) Aleixo Muise, MD PhD FRCPC The Genome Scan in IBD Objectives: To identify patients who should

More information

Immunodeficiency. By Dr. Gouse Mohiddin Shaik

Immunodeficiency. By Dr. Gouse Mohiddin Shaik Immunodeficiency By Dr. Gouse Mohiddin Shaik Immunodeficieny Immunodeficiency is failure of immune system to protect against disease or malignency Immunodeficiency is of two types Primary Secondary immunodeficiency

More information

ORIGINAL RESEARCH. J Clin Immunol (2015) 35: DOI /s

ORIGINAL RESEARCH. J Clin Immunol (2015) 35: DOI /s J Clin Immunol (2015) 35:696 726 DOI 10.1007/s10875-015-0201-1 ORIGINAL RESEARCH Primary Immuno Diseases: an Update on the Classification from the International Union of Immunological Societies Expert

More information

Genetic testing for hereditary cancer. An overview for healthcare providers

Genetic testing for hereditary cancer. An overview for healthcare providers Genetic testing for hereditary cancer An overview for healthcare providers Specimen requirements Whole blood Two 4.5 ml EDTA tubes (lavender top) Please wait at least 2 weeks after a packed cell/platelet

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles Multimethod Analysis of 25+ Hematologic Diseases and Solid Tumors Anatomic Pathology FISH Molecular The next generation of diagnostic, prognostic, and therapeutic assessment NeoTYPE

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Lindsley RC, Saber W, Mar BG, et al. Prognostic mutations in

More information

Jocelyn Chapman, MD Division of Gynecologic Oncology. Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic

Jocelyn Chapman, MD Division of Gynecologic Oncology. Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic Jocelyn Chapman, MD Division of Gynecologic Oncology Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic Genetics underlies all cancers Somatic or tumor genetics Germline or inherited genetics

More information

Chapter 2. Diagnostic Evaluation of FA. Definition of Fanconi Anemia. The Importance of Early Diagnosis. Blanche P. Alter, MD, MPH, FAAP

Chapter 2. Diagnostic Evaluation of FA. Definition of Fanconi Anemia. The Importance of Early Diagnosis. Blanche P. Alter, MD, MPH, FAAP Chapter 2 Diagnostic Evaluation of FA Blanche P. Alter, MD, MPH, FAAP Definition of Fanconi Anemia Fanconi anemia is an autosomal recessive disorder associated with a very high frequency of bone marrow

More information

Clinical Immunodeficiency. Dr Claire Bethune Consultant Immunologist

Clinical Immunodeficiency. Dr Claire Bethune Consultant Immunologist Clinical Immunodeficiency Dr Claire Bethune Consultant Immunologist Peninsula Specialist Immunodeficiency and Allergy service Eden Unit, Derriford https://www.plymouthhospitals.nhs. uk/eden Or Google Immunology

More information

7/12/2016 TESTING. Objectives. New Directions in Aplastic Anemia: What's on the Horizon? Better way to evaluate clonal evolution?

7/12/2016 TESTING. Objectives. New Directions in Aplastic Anemia: What's on the Horizon? Better way to evaluate clonal evolution? New Directions in Aplastic Anemia: What's on the Horizon? Amy E. DeZern, MD; MHS Assistant Professor Hematologic Malignancies Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, MD Objectives

More information

Case Presentations in Primary Immune Deficiency Diseases. John W. Sleasman, M.D. St Petersburg, FL Mark Ballow, M.D. Buffalo NY & Sarasota, FL

Case Presentations in Primary Immune Deficiency Diseases. John W. Sleasman, M.D. St Petersburg, FL Mark Ballow, M.D. Buffalo NY & Sarasota, FL Case Presentations in Primary Immune Deficiency Diseases John W. Sleasman, M.D. St Petersburg, FL Mark Ballow, M.D. Buffalo NY & Sarasota, FL COPD and recurrent infections 42 WF non- smoker with diagnosis

More information

Out-Patient Billing CPT Codes

Out-Patient Billing CPT Codes Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB

More information

The Next Generation of Hereditary Cancer Testing

The Next Generation of Hereditary Cancer Testing The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,

More information

FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:

FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship: REQUEST FOR GERMLINE BAP1TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST NAME MI LAST

More information

A genome-wide association study identifies vitiligo

A genome-wide association study identifies vitiligo A genome-wide association study identifies vitiligo susceptibility loci at MHC and 6q27 Supplementary Materials Index Supplementary Figure 1 The principal components analysis (PCA) of 2,546 GWAS samples

More information

CALIFORNIA NEWBORN SCREENING FOR SCID. Joseph A. Church, M.D. Children s Hospital Los Angeles and Keck School of Medicine at U.S.C.

CALIFORNIA NEWBORN SCREENING FOR SCID. Joseph A. Church, M.D. Children s Hospital Los Angeles and Keck School of Medicine at U.S.C. CALIFORNIA NEWBORN SCREENING FOR SCID Joseph A. Church, M.D. Children s Hospital Los Angeles and Keck School of Medicine at U.S.C. CELLS, DNA AND GENES HOW GENES GO WRONG - MUTATIONS MONOGENIC TRAIT: Determined

More information

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other:

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other: REQUEST FOR BECKWITH-WIEDEMANN SYNDROME (BWS) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION

More information

Chapter 26. Newborn Screening

Chapter 26. Newborn Screening Chapter 26 Newborn Screening Severe Combined Immune Deficiency (SCID) leads to life-threatening infections unless the immune system can be restored through a bone marrow transplant, enzyme replacement

More information

Movement Disorders Requisition Form

Movement Disorders Requisition Form Movement Disorders Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax:

More information

Hemophagocytic Lymphohistiocytosis Pre-HCT Data

Hemophagocytic Lymphohistiocytosis Pre-HCT Data Instructions for Hemophagocytic Lymphohistiocytosis Pre-HCT Data (Form 2039) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Hemophagocytic Lymphohistiocytosis

More information

Immunodeficiency and Skin (September 21, 2018) By (Arti Nanda, MD, DNBE [Kuwait])

Immunodeficiency and Skin (September 21, 2018) By (Arti Nanda, MD, DNBE [Kuwait]) Immunodeficiency and Skin (September 21, 2018) By (Arti Nanda, MD, DNBE [Kuwait]) Immune deficiency refers to a state in which part of immune system is missing or defective resulting into an inability

More information

INHERITED NEUTROPENIAS. Joshua Morales M.D. Chief Hematology-Oncology Fellow 02/22/2017

INHERITED NEUTROPENIAS. Joshua Morales M.D. Chief Hematology-Oncology Fellow 02/22/2017 INHERITED NEUTROPENIAS Joshua Morales M.D. Chief Hematology-Oncology Fellow 02/22/2017 Objectives Review neutropenia classifications Define chronic severe neutropenia Review diagnostic approach to neutropenia

More information

Immunodeficiency. (1 of 2)

Immunodeficiency. (1 of 2) Immunodeficiency (1 of 2) Primary immunodeficiency diseases Innate or adaptive Most are detected in infancy (6 months 2 years) Rare but some mild genetic forms exist in many individuals Defects in Innate

More information

Transduction of lentivirus to human primary CD4+ T cells

Transduction of lentivirus to human primary CD4+ T cells Transduction of lentivirus to human primary CD4 + T cells Human primary CD4 T cells were stimulated with anti-cd3/cd28 antibodies (10 µl/2 5 10^6 cells of Dynabeads CD3/CD28 T cell expander, Invitrogen)

More information

August 17, Dear Valued Client:

August 17, Dear Valued Client: August 7, 08 Re: CMS Announces 6-Month Period of Enforcement Discretion for Laboratory Date of Service Exception Policy Under the Medicare Clinical Laboratory Fee Schedule (the 4 Day Rule ) Dear Valued

More information

Phenotypes and genotypes of the chromosomal instability syndromes

Phenotypes and genotypes of the chromosomal instability syndromes Rare Diseases Column (Review Article) Phenotypes and genotypes of the chromosomal instability syndromes Zhan-He Wu Western Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children s Hospital

More information

Wiskott-Aldrich Registry Data Collection Form Patient Identification: Patient Name (first, middle, last)

Wiskott-Aldrich Registry Data Collection Form Patient Identification: Patient Name (first, middle, last) Patient Identification: Patient Name (first, middle, last) Patient s USIDNET Registry Number assigned after online enrollment Date of Birth / / (mm/dd/yyyy) or Year of Birth Gender: male [ ], female [

More information

Constitutional Aplastic Anemias. Uma Kundu, M.D. July 17, 2006

Constitutional Aplastic Anemias. Uma Kundu, M.D. July 17, 2006 Constitutional Aplastic Anemias Uma Kundu, M.D. July 17, 2006 Overview Erythroid lineage only (pure red cell aplasia) Two cell lines (bicytopenia) All hematopoietic cells (aplastic anemia) Aplastic anemias

More information

DNA Genetic Cancer Risk Test. Test Report

DNA Genetic Cancer Risk Test. Test Report Test Report CONTENTS SECTION 1 1-1. Customer Information 1-2. Test Report Summary 1-3. Test Report Details 1-4. List of Cancers / Tumors Tested SECTION 2 2-1. About the Test 2-2. References 1 CL0040-1_B

More information

UKGTN Testing Criteria Test name: Chromosome breakage disorders 61 Gene Panel

UKGTN Testing Criteria Test name: Chromosome breakage disorders 61 Gene Panel UKGTN Testing Criteria Test name: Chromosome breakage disorders 61 Gene Panel Approved name disorder/(s): See appendix 1 Approved name (s): See appendix 1 (s): (s): Patient name: Patient postcode: Date

More information

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Talking Genomes with Your Patients Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Objectives Review the importance of physician familiarity with genomic testing

More information

Allergy and Immunology Review Corner: Chapter 15 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Allergy and Immunology Review Corner: Chapter 15 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Allergy and Immunology Review Corner: Chapter 15 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Chapter 15: Clinical Immunology of Parasitic Diseases Prepared

More information

The Center for PERSONALIZED DIAGNOSTICS

The Center for PERSONALIZED DIAGNOSTICS The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Allogeneic Hematopoietic Transplant for Genetic Diseases and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: allogeneic_hematopoietic_transplant_for_genetic_diseases

More information

Aplastic Anemia: Understanding your Disease and Treatment Options

Aplastic Anemia: Understanding your Disease and Treatment Options Aplastic Anemia: Understanding your Disease and Treatment Options No financial relationships or commercial interest related to the content of this presentation Josh Sasine, MD, PhD Hematopoietic Cell Transplant

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles 30+ Multimethod Assays for Hematologic Diseases and Solid Tumors Molecular FISH Anatomic Pathology The next generation of diagnostic, prognostic, and therapeutic assessment What

More information

Russell-Silver syndrome (RSS)

Russell-Silver syndrome (RSS) GENETIC DIAGNOSTIC LABORATORY Russell-Silver syndrome (RSS) Background: Russell-Silver syndrome (RSS, OMIM 103280, 180860) is a growth disorder characterized by intrauterine and postnatal growth retardation,

More information

SUPPLEMENTAL DATA. Table S1. Genes in each pathway selected for analysis.

SUPPLEMENTAL DATA. Table S1. Genes in each pathway selected for analysis. SUPPLEMENTAL DATA Table S1. Genes in each pathway selected for analysis. Gene Chr Start End bp Pathway 1 AKR1C1 10 5000044 5022159 22115 COX 2 AKR1C2 10 5029967 5060207 30240 COX 3 AKR1C3 10 5077549 5149878

More information

HYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist.

HYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist. HYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist. 1 HYPER IgM SYNDROME Also available : COMMON VARIABLE IMMUNODEFICIENCY

More information

BRCA Precertification Information Request Form

BRCA Precertification Information Request Form BRCA Precertification Information Request Form Failure to complete this form in its entirety may result in the delay of review. Fax to: BRCA Precertification Department Fax number: 1-860-975-9126 Section

More information

From the Diagnostic Immunology Laboratories

From the Diagnostic Immunology Laboratories From the Diagnostic ISSUE 10 SPRING 2013 PAGE 1 Spring Meeting Please stop by and say hello in April at this year s American Society of Pediatric Hematology/Oncology (ASPHO) Annual Meeting in Miami, Florida.

More information

Newborn Screening for SCID and T Cell Lymphopenia

Newborn Screening for SCID and T Cell Lymphopenia Newborn Screening for SCID and T Cell Lymphopenia Jennifer Puck, MD Jennifer.Puck@ucsf.edu Department of Pediatrics University of California San Francisco and Benioff Children s Hospital San Francisco,

More information

Nature Genetics: doi: /ng Supplementary Figure 1

Nature Genetics: doi: /ng Supplementary Figure 1 Supplementary Figure 1 Characterization of HPV Tg/+ ; Krt17 / mice. (a) Macroscopic images of HPV16 Tg/+ mouse ears at P40, P70 and P120. (b) Immunostaining of HPV16 Tg/+ ear tissue sections for K17 (red)

More information

Intellectual Disability Exome Panel Requisition Form

Intellectual Disability Exome Panel Requisition Form Intellectual Disability Exome Panel Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local:

More information

Chapter 11. Hyper IgM Syndromes

Chapter 11. Hyper IgM Syndromes Chapter 11 Hyper IgM Syndromes Patients with Hyper-IgM (HIGM) syndrome are susceptible to recurrent and severe infections and in some types of HIGM syndrome opportunistic infections and an increased risk

More information

The histopathology of bone marrow failure in children

The histopathology of bone marrow failure in children Journal of clinical and experimental hematopathology Vol. 58 No.2, 68-86, 2018 JC lin EH xp ematopathol Review Article The histopathology of bone marrow failure in children Hideto Iwafuchi Bone marrow

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our

More information

Deconvolution of Heterogeneous Wound Tissue Samples into Relative Macrophage Phenotype Composition via Models based on Gene Expression

Deconvolution of Heterogeneous Wound Tissue Samples into Relative Macrophage Phenotype Composition via Models based on Gene Expression Electronic Supplementary Material (ESI) for Integrative Biology. This journal is The Royal Society of Chemistry 2017 Supplementary Information for: Deconvolution of Heterogeneous Wound Tissue Samples into

More information

YES. If yes, indicate what types of tumors/polyps and age of onset:

YES. If yes, indicate what types of tumors/polyps and age of onset: REQUEST FOR FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Bone marrow morphology in III-2 of family A.

Nature Genetics: doi: /ng Supplementary Figure 1. Bone marrow morphology in III-2 of family A. Supplementary Figure 1 Bone marrow morphology in III-2 of family A. (a) Pre-transplant peripheral blood smears from patient III-2 illustrating hypogranulated neutrophils (left) and hypolobated neutrophils

More information

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with

More information

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data Key Fields Sequence Number: Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Has this patient's data been previously reported to USIDNET? USIDNET ID: Today's Date: - - Date of HSCT for which

More information

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5 Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition

More information

Genetic testing for hereditary cancer

Genetic testing for hereditary cancer Genetic testing for hereditary cancer THE GENETICS OF HEREDITARY CANCER About half of all men and one-third of all women in the US will develop cancer during their lifetimes. Approximately 5% to 10% of

More information

* Kyoto Encyclopedia of Genes and Genomes.

* Kyoto Encyclopedia of Genes and Genomes. Supplemental Material Complete gene expression data using Affymetrix 3PRIME IVT ID Chip (54,614 genes) and human immature dendritic cells stimulated with rbmasnrs, IL-8 and control (media) has been deposited

More information

Disclosers Updates: Management of Aplastic Anemia and Congenital Marrow Failure 5/9/2017

Disclosers Updates: Management of Aplastic Anemia and Congenital Marrow Failure 5/9/2017 2017 Updates: Management of Aplastic Anemia and Congenital Marrow Failure Sachit Patel, MD Department of Pediatrics Division of Hematology-Oncology Blood and Marrow Transplantation Disclosers None 1 Objectives:

More information

Outline. What is aplastic anemia? 9/19/2012. Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options

Outline. What is aplastic anemia? 9/19/2012. Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options Carlos M. de Castro, MD Duke University Medical Center Outline What is Aplastic Anemia? What other diseases

More information

PANELES PARA ESTUDIOS GENÉTICOS

PANELES PARA ESTUDIOS GENÉTICOS PANELES PARA ESTUDIOS GENÉTICOS Ante cualquier duda o consulta, puede escribirnos a: estudiosgeneticos@labmedicina.com EXÁMENES PARA CÁNCER HEREDITARIO Panel de Cáncer Hereditario - Principales Genes (37

More information

Qualitative Neutrophil Disorders. Joshua Morales M.D. Chief Hematology-Oncology Fellow March 1 st, 2017

Qualitative Neutrophil Disorders. Joshua Morales M.D. Chief Hematology-Oncology Fellow March 1 st, 2017 Qualitative Neutrophil Disorders Joshua Morales M.D. Chief Hematology-Oncology Fellow March 1 st, 2017 Objectives Review normal neutrophil function and movement Review the enzymatic reactions in neutrophil

More information

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention Know the Basics Breast cancer is the most common cancer in women

More information

From the Diagnostic Immunology Laboratories

From the Diagnostic Immunology Laboratories Immunology Laboratories ISSUE 9 SPRING 2012 PAGE 1 Spring Meetings Please stop by and say hello in May at this year s American Society of Pediatric Hematology/Oncology (ASPHO) Annual Meeting in New Orleans

More information

Disclosures. Newborn Screening for Severe Combined Immune Deficiency Syndromes (SCIDS): Why; why now? Learning objectives.

Disclosures. Newborn Screening for Severe Combined Immune Deficiency Syndromes (SCIDS): Why; why now? Learning objectives. Newborn Screening for Severe Combined Immune Deficiency Syndromes (SCIDS): Why; why now? Anthony J. Infante, MD, PhD Professor, Pediatrics and Microbiology & Immunology Chief, Division of Immunology &

More information

PRIMARY IMMUNODEFICIENCIES CVID MANAGEMENT CVID MANAGEMENT

PRIMARY IMMUNODEFICIENCIES CVID MANAGEMENT CVID MANAGEMENT PRIMARY IMMUNODEFICIENCIES CVID MANAGEMENT CVID MANAGEMENT 1 PRIMARY IMMUNODEFICIENCIES KEY ABBREVIATIONS CVID CT IgA IgG IgM IPOPI IVIG SCIG PID Common Variable Immune Deficiency Computerised tomography

More information

Table of Contents. Introduction Autoimmune Lymphoproliferative Syndrome Absolute T Bruton s Tyrosine Kinase...

Table of Contents. Introduction Autoimmune Lymphoproliferative Syndrome Absolute T Bruton s Tyrosine Kinase... Table of Contents Introduction... 2 Autoimmune Lymphoproliferative Syndrome... 3 Absolute T4... 4 Bruton s Tyrosine Kinase... 5 Common Variable Immunodeficiency... 6 Cytotoxicity/Apoptosis... 7 Hyper IgM...

More information

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014 A Practical Approach to Leukopenia/Neutropenia in Children Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014 Disclosures EPIC trial MAST Therapeutics SUSTAIN trial Selexys Pharmaceuticals

More information

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018 The function of the bone marrow Larry D. Cripe, MD Indiana University Simon Cancer Center Bone Marrow Stem Cells Mature into Blood Cells Mature Blood Cells and Health Type Function Term Red Cells Carry

More information